We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$2.53B
AUM Growth
+$68.3M
Cap. Flow
+$49.5M
Cap. Flow %
1.96%
Top 10 Hldgs %
16.36%
Holding
1,009
New
121
Increased
515
Reduced
261
Closed
111

Top Sells

Rank Stock Value
1
OII icon
Oceaneering
OII
+$17.5M
2
ZBRA icon
Zebra Technologies
ZBRA
+$12.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.2M
4
IPGP icon
IPG Photonics
IPGP
+$7.17M
5
IRBT
iRobot
IRBT
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 26.96%
2 Industrials 13.04%
3 Healthcare 11.78%
4 Consumer Discretionary 8.78%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRC icon
501
Kilroy Realty
KRC
$4.42B
$768K 0.03%
10,144
-1,296
-11% -$95K
DXCM icon
502
DexCom
DXCM
$32B
$765K 0.03%
+32,244
New +$684K
MKTX icon
503
MarketAxess Holdings
MKTX
$5.72B
$761K 0.03%
+3,845
New +$797K
OKE icon
504
Oneok
OKE
$54.5B
$760K 0.03%
10,879
+910
+9% +$58.6K
XRAY icon
505
Dentsply Sirona
XRAY
$2.43B
$758K 0.03%
17,336
+6,627
+62% +$311K
AAT
506
American Assets Trust
AAT
$1.4B
$757K 0.03%
19,772
+12,160
+160% +$430K
AWK icon
507
American Water Works
AWK
$26.9B
$756K 0.03%
8,860
-146
-2% -$12.1K
OPLN
508
Openlane
OPLN
$4.54B
$754K 0.03%
36,346
-24,814
-41% -$506K
O icon
509
Realty Income
O
$59.1B
$753K 0.03%
14,450
+5,513
+62% +$279K
ALNY icon
510
Alnylam Pharmaceuticals
ALNY
$29.3B
$751K 0.03%
7,623
+3,157
+71% +$313K
MRO
511
DELISTED
Marathon Oil Corporation
MRO
$750K 0.03%
35,912
-6,292
-15% -$124K
CHTR icon
512
Charter Communications
CHTR
$18.2B
$740K 0.03%
2,523
-1,439
-36% -$413K
CELG
513
DELISTED
Celgene Corp
CELG
$739K 0.03%
9,304
+1,677
+22% +$139K
SPLK
514
DELISTED
Splunk Inc
SPLK
$737K 0.03%
+7,434
New +$808K
TJX icon
515
TJX Companies
TJX
$178B
$735K 0.03%
15,436
-1,596
-9% -$70.1K
AEE icon
516
Ameren
AEE
$30.1B
$733K 0.03%
12,051
-1,656
-12% -$95.2K
PFPT
517
DELISTED
Proofpoint, Inc.
PFPT
$729K 0.03%
+6,320
New +$768K
SBUX icon
518
Starbucks
SBUX
$120B
$728K 0.03%
14,899
-510
-3% -$28.9K
RPM icon
519
RPM International
RPM
$15B
$725K 0.03%
12,439
-9,037
-42% -$453K
NSP icon
520
Insperity
NSP
$2.01B
$716K 0.03%
7,513
+3,497
+87% +$301K
WDAY icon
521
Workday
WDAY
$44.4B
$715K 0.03%
+5,901
New +$756K
TOL icon
522
Toll Brothers
TOL
$14.5B
$711K 0.03%
19,230
+288
+2% +$11.8K
DCT
523
DELISTED
DCT Industrial Trust Inc.
DCT
$711K 0.03%
10,660
+2,567
+32% +$161K
AGO icon
524
Assured Guaranty
AGO
$3.34B
$707K 0.03%
+19,799
New +$720K
KHC icon
525
Kraft Heinz
KHC
$30B
$703K 0.03%
11,193
-3
-0% -$178

Similar funds

Vident Investment Advisory's Q2 2018 Portfolio in Review

As of Q2 2018, Vident Investment Advisory held 1,009 positions worth $2.53B, up 2.8% from $2.46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Investment Advisory's Q2 2018 filing shows 121 new, 515 increased, 261 reduced and 111 closed positions. Its largest new stake was Arcus Biosciences: 156,139 shares worth $1.91M. The largest sale was Oceaneering, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Vident Investment Advisory's largest Q2 2018 buy was Arcus Biosciences: 156,139 shares worth $1.91M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $29.4M increase.
  • Vident Investment Advisory's biggest Q2 2018 reduction was Oceaneering, cutting an estimated $17.5M.
  • Vident Investment Advisory fully exited FIRST TRUST HIGH INCOME LONG/SHORT FUND in Q2 2018, selling an estimated $5.5M.
  • Vident Investment Advisory's ten largest holdings make up 16% of its $2.53B portfolio in Q2 2018.
  • Vident Investment Advisory opened 121 new positions and closed 111 in Q2 2018.
  • Vident Investment Advisory's portfolio value rose 2.8% quarter-over-quarter to $2.53B.

Based on Vident Investment Advisory's 13F filing for Q2 2018, filed 14 Aug 2018.